H Grant Skaggs Jr
Examiner (ID: 16447)
Most Active Art Unit | 3101 |
Art Unit(s) | 3651, 1301, 3615, 3653, 2899, 3101 |
Total Applications | 2062 |
Issued Applications | 1836 |
Pending Applications | 39 |
Abandoned Applications | 187 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6417350
[patent_doc_number] => 20100167272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Method for Detecting and Analyzing Pathogens in a Sample'
[patent_app_type] => utility
[patent_app_number] => 12/668830
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16953
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668830
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668830 | Method for Detecting and Analyzing Pathogens in a Sample | Jul 10, 2008 | Abandoned |
Array
(
[id] => 6292762
[patent_doc_number] => 20100239610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT'
[patent_app_type] => utility
[patent_app_number] => 12/669033
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 89
[patent_no_of_words] => 38646
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12669033
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/669033 | INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT | Jul 10, 2008 | Abandoned |
Array
(
[id] => 6142232
[patent_doc_number] => 20110129489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR'
[patent_app_type] => utility
[patent_app_number] => 12/452494
[patent_app_country] => US
[patent_app_date] => 2008-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14941
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129489.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452494 | METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR | Jul 6, 2008 | Abandoned |
Array
(
[id] => 5465670
[patent_doc_number] => 20090325870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'FOAMY VIRAL ENVELOPE GENES'
[patent_app_type] => utility
[patent_app_number] => 12/147947
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 13413
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325870.pdf
[firstpage_image] =>[orig_patent_app_number] => 12147947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/147947 | Foamy viral envelope genes | Jun 26, 2008 | Issued |
Array
(
[id] => 5508040
[patent_doc_number] => 20090081247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Immune adjuvant comprising ATP'
[patent_app_type] => utility
[patent_app_number] => 12/213874
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5119
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081247.pdf
[firstpage_image] =>[orig_patent_app_number] => 12213874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/213874 | Immune adjuvant comprising ATP | Jun 24, 2008 | Abandoned |
Array
(
[id] => 6292742
[patent_doc_number] => 20100239609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification'
[patent_app_type] => utility
[patent_app_number] => 12/598749
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6988
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239609.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598749
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598749 | Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification | Apr 29, 2008 | Abandoned |
Array
(
[id] => 4959713
[patent_doc_number] => 20080274138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification'
[patent_app_type] => utility
[patent_app_number] => 12/112191
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6995
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12112191
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/112191 | Formulation of sugar solutions for continuous ultracentrifugation for virus purification | Apr 29, 2008 | Issued |
Array
(
[id] => 80718
[patent_doc_number] => 07744900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Enhancement of the immune response for vaccine and gene therapy applications'
[patent_app_type] => utility
[patent_app_number] => 12/111305
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 14899
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/744/07744900.pdf
[firstpage_image] =>[orig_patent_app_number] => 12111305
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/111305 | Enhancement of the immune response for vaccine and gene therapy applications | Apr 28, 2008 | Issued |
Array
(
[id] => 6500867
[patent_doc_number] => 20100215696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'EFFICIENTLY REPLICABLE HEPTITIS C VIRUS MUTANT, A HEPTITIS C VIRUS MUTANT COMPRISING REPORTER GENE, A METHOD OF PREPARING OF HCV VACCINE USING THE SAME AND A METHOD OF SCREENING ANTI HCV COMPOSITION USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/597747
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 10599
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215696.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597747 | EFFICIENTLY REPLICABLE HEPTITIS C VIRUS MUTANT, A HEPTITIS C VIRUS MUTANT COMPRISING REPORTER GENE, A METHOD OF PREPARING OF HCV VACCINE USING THE SAME AND A METHOD OF SCREENING ANTI HCV COMPOSITION USING THE SAME | Apr 27, 2008 | Abandoned |
Array
(
[id] => 6581350
[patent_doc_number] => 20100291090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Prion Protein as a Receptor for Amyloid-Beta Oligomers'
[patent_app_type] => utility
[patent_app_number] => 12/597535
[patent_app_country] => US
[patent_app_date] => 2008-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 47066
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291090.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597535 | Prion protein as a receptor for amyloid-β oligomers | Apr 27, 2008 | Issued |
Array
(
[id] => 5501668
[patent_doc_number] => 20090162356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'CRIg antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/150220
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 17926
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12150220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/150220 | CRIg antagonists | Apr 24, 2008 | Abandoned |
Array
(
[id] => 6353360
[patent_doc_number] => 20100086556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'USE OF HEMAGGLUTININ OF THE AFRICAN SWINE FEVER VIRUS AS AN ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 12/596326
[patent_app_country] => US
[patent_app_date] => 2008-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9883
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12596326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/596326 | USE OF HEMAGGLUTININ OF THE AFRICAN SWINE FEVER VIRUS AS AN ADJUVANT | Apr 16, 2008 | Abandoned |
Array
(
[id] => 6589026
[patent_doc_number] => 20100291598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'PRION ELISA'
[patent_app_type] => utility
[patent_app_number] => 12/450634
[patent_app_country] => US
[patent_app_date] => 2008-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14542
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450634
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450634 | PRION ELISA | Apr 3, 2008 | Abandoned |
Array
(
[id] => 6323342
[patent_doc_number] => 20100196934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'PRION ASSAY'
[patent_app_type] => utility
[patent_app_number] => 12/450636
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20778
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196934.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450636
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450636 | PRION ASSAY | Apr 2, 2008 | Abandoned |
Array
(
[id] => 4467975
[patent_doc_number] => 07943148
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-05-17
[patent_title] => 'Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/061067
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12904
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943148.pdf
[firstpage_image] =>[orig_patent_app_number] => 12061067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/061067 | Amino acid sites in Flavivirus E proteins useful for development of diagnostics and vaccines | Apr 1, 2008 | Issued |
Array
(
[id] => 4813289
[patent_doc_number] => 20080193920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Methods and systems for producing recombinant viral antigens'
[patent_app_type] => utility
[patent_app_number] => 12/077046
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27059
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193920.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077046
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077046 | Method for detecting NANBV associated seroconversion | Mar 13, 2008 | Issued |
Array
(
[id] => 4821733
[patent_doc_number] => 20080227111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'REAGENT KIT AND METHOD FOR MEASURING HCV ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/048709
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8946
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227111.pdf
[firstpage_image] =>[orig_patent_app_number] => 12048709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/048709 | REAGENT KIT AND METHOD FOR MEASURING HCV ANTIBODY | Mar 13, 2008 | Abandoned |
Array
(
[id] => 4699031
[patent_doc_number] => 20080221215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'ANTIVIRAL INHIBITION OF CAPSID PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/047789
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 11675
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047789 | ANTIVIRAL INHIBITION OF CAPSID PROTEINS | Mar 12, 2008 | Abandoned |
Array
(
[id] => 4954532
[patent_doc_number] => 20080187556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Medicine for Treating Tumor and Use Therefor in Preparation of the Medicaments for Treating Tumor'
[patent_app_type] => utility
[patent_app_number] => 12/042367
[patent_app_country] => US
[patent_app_date] => 2008-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5871
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12042367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/042367 | Medicine for Treating Tumor and Use Therefor in Preparation of the Medicaments for Treating Tumor | Mar 4, 2008 | Abandoned |
Array
(
[id] => 9239370
[patent_doc_number] => 08604161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Prion protein ligands and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/035917
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 16856
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12035917
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/035917 | Prion protein ligands and methods of use | Feb 21, 2008 | Issued |